Susquehanna International Group
AEMD icon

Susquehanna International Group’s Aethlon Medical AEMD Stock Holding History

Susquehanna International Group’s Portfolio AEMD Stock Details AEMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-117
Closed -$54K – 12279
2022
Q3 		$54K Buy
+117
New +$101K ﹤0.01% 12144
2021
Q4 		– Sell
-54
Closed -$166K – 13031
2021
Q3 		$166K Buy
+54
New +$181K ﹤0.01% 11694

Other funds holding AEMD

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Susquehanna International Group's AEMD Position: Q3 2024 in Review

Susquehanna International Group sold out of Aethlon Medical (AEMD) in Q3 2024, closing a stake of 458 shares — an estimated $18.3K sold.

Susquehanna International Group first reported a position in AEMD in Q2 2018 and held it in 8 quarters. The position peaked at $66K in Q2 2018. 15 funds tracked by Wall St. Rank hold AEMD as of Q3 2024.

  • Susquehanna International Group reported no remaining Aethlon Medical position as of Q3 2024 after selling out during the quarter.
  • Susquehanna International Group sold 458 Aethlon Medical shares in Q3 2024, an estimated $18.3K.
  • Susquehanna International Group first reported a position in Aethlon Medical in Q2 2018 and held it in 8 quarters.
  • Susquehanna International Group's Aethlon Medical position peaked at $66K in Q2 2018.
  • 15 funds tracked by Wall St. Rank held Aethlon Medical as of Q3 2024.

Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.